@inproceedings{2951563,
    title = "Randomized phase 2 trial of bortezomib-dexamethasone (VD) versus VD plus cyclophosphamide or lenalidomide in myeloma patients achieving stable disease after 4 cycles of VD as second-line treatment",
    author = "Dimopoulos, M and Roddie, H and Beksac, M and Benboubker, L and de la Rubia, J and Casado, L and Allietta, N and Angermund, R and Facon, T",
    year = "2010",
    pages = "147--148",
    booktitle = "HAEMATOLOGICA-THE HEMATOLOGY JOURNAL"
}